We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi Acquires Principia for $3.7 Billion, Gaining Control of Promising MS Drug
Sanofi Acquires Principia for $3.7 Billion, Gaining Control of Promising MS Drug
Sanofi has agreed to pay $3.7 billion for San Francisco-based Principia Biopharma, giving the French drugmaker full control of a potential multiple sclerosis drug.